Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled AP301 for primary graft dysfunction after lung transplantation
2013-000716-21Phase 2Completed
- Sponsor
- APEPTICO
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary graft dysfunction (PGD) comparing AP301 inhalation with Placebo inhalation (2 arms). Started Apr 2013; status: completed.
02
Drugs
AP301
03
Conditions
primary graft dysfunction (PGD)
Beyond the preview
Go deeper on 2013-000716-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000716-21.